Isolation, characterization, and transplantation of candidate stem cells
Isolation, characterization, and transplantation of candidate stem cells
批准号:
8344826
负责人:
John Tisdale
金额:
$61.31万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
ABCG2 geneATP-Binding Cassette TransportersAdultAffectAlbuminsAllogenicAnimal ModelAntigensBackBenignBeta CellBiological AssayBone MarrowBone Marrow CellsBone Marrow TransplantationBromodeoxyuridineCD34 AntigensCD34 geneCYP2B6 geneCarbonCell LineageCell NucleusCellsChloride IonChloridesClinical InvestigatorCulture MediaCultured CellsCytochrome P450Cytokeratin 18Cytokeratin 8CytoplasmCytoplasmic GranulesDNADiseaseDoseDyesEngraftmentFlow CytometryGene Expression ProfileGlobinHematopoiesisHematopoieticHematopoietic Stem Cell TransplantationHematopoietic stem cellsHepaticHepatocyteHumanIndividualInsulin-Dependent Diabetes MellitusKnowledgeLabelLeadLifeLiverLiver Function TestsMalignant - descriptorMethodsMicroarray AnalysisModelingMolecularMusNOD/SCID mouseNatural regenerationOrganPancreasPhenotypePopulationReverse Transcriptase Polymerase Chain ReactionSamplingSideSirolimusSourceSpeedStaining methodStainsStem cellsStressTechniquesTestingTimeTransplantationWorkXenograft Modelaccelerator mass spectrometryalpha 1-Antitrypsinbaseclinical applicationclinical practicehuman diseasein vivoirradiationmeetingsreconstitutionrepairedsuccessvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hematopoietic stem cells reside within the bone marrow post-natally, providing all hematopoietic lineages for the life of the host, and their extensive characterization over the last several decades has led to clinical application including bone marrow transplantation for benign and malignant disorders affecting the hematopoietic compartment. Isolation of bone marrow cells based upon expression of the CD34 antigen enriches for the primitive compartment, and techniques to isolate the CD34-positive population are commonly used in clinical practice. Assays for true hematopoietic stem cells require transplantation and repopulation, and thus studies querying such potential among human cells are difficult. We have thus developed a xenograft model with robust human hematopoietic stem cell engraftment, and have demonstrated engraftment of all cell lineages. This assay will allow us to test globin vectors for the first time among engrafted human cells in a relevant model.
Recently, a method for the isolation of murine bone marrow cells capable of reconstituting hematopoiesis after lethal irradiation based solely upon dual wavelength flow cytometry after staining with the vital dye, Hoechst 33342, was described by Goodell et. al. The molecular basis of these side population cells was recently attributed to expression of the ABC transporter, ABCG2. Side population (SP) cells are highly enriched for hematopoietic repopulating ability, with one cell capable of reconstituting hematopoiesis in irradiated recipient mice. We reasoned that this phenotype is conserved among organs with the capacity for post-natal regeneration. We have recently isolated SP cells from the non-parynchymal portion of human cadaveric liver and have cultured these cells in hepatic culture media. Hepatic SP cells generated colonies of cells demonstrating granule rich cytoplasm and dense, often double nuclei consistent with hepatocytes. These hepatocyte-like cells expressed markers of human hepatocytes including HepPar, cytokeratin-8, and human albumin. RT-PCR confirmed the expression of hepatocyte markers including albumin, cytokeratin-18, along with the more specific markers, alpha-1-antitrypsin and the human P450 gene, CYP2B6. We have now developed an in vivo rescue model in NOD/SCID mice treated with sublethal dosing of carbon-tetra-chloride, and initial results suggest that SP cells are capable of affecting a normalization of liver function test similar to mature hepatocytes when compared to controls. Further in vivo characterization of these SP cells is ongoing. Additionally, SP cells have been isolated from the adult pancreas, and microarray analysis demonstrates gene expression profile similar to that of bone marrow derived SP cells. Initial attempts to differentiate pancreatic SP cells toward a mature beta-cell phenotype have met with only limited success and these studies are ongoing, yet their quiescence in culture raises the question whether beta-cells can regenerate in adult hosts. We have thus developed a method for assessing beta cell regeneration post-natally using 14C dating by accelerator mass spectrometry. Initial results suggest limited turnover. Further, samples from individuals who received the DNA labeling agents BrdU and IdU were obtained and analyzed for evidence of turnover. These samples also suggest limited turnover of adult beta cells. We have thus turned back to animal models to further query the potential for tolerance induction in Type I diabetes mellitus, as this tolerance will be necessary in a number of disease states, including our main focus, allogeneic hematopoietic stem cell transplantation. Studies are ongoing utilizing rapamycin, an agent we have demonstrated to achieve operational tolerance in animal models and humans, to determine if this agent can lead to antigen specific tolerance in a naturally occurring model of Type I dieabetes in the mouse. This work will be used to support collaborative studies with clinical investigators in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
14C AS A MARKER FOR BETA CELL TURNOVER IN ADULT HUMANS
-
批准号:8362759
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2011
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:10467904
-
项目类别:
-
资助金额:$116.21万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Nonmyeloablative allogeneic PBSC in globin disorders
-
批准号:7337573
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Isolation, characterization, and transplantation of candidate stem cells
-
批准号:8557973
-
项目类别:
-
资助金额:$58.6万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:8939814
-
项目类别:
-
资助金额:$51.78万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Isolation, characterization, and transplantation of candidate stem cells
-
批准号:9157366
-
项目类别:
-
资助金额:$56.41万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Nonmyeloablative allogeneic PBSC in globin disorders
-
批准号:7593475
-
项目类别:
-
资助金额:$56.02万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Isolation, characterization, and transplantation of candidate stem cells
-
批准号:7593477
-
项目类别:
-
资助金额:$32.01万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:8149537
-
项目类别:
-
资助金额:$91.16万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Nonmyeloablative allogeneic PBSC in globin disorders
-
批准号:8557971
-
项目类别:
-
资助金额:$132.25万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:7969163
-
项目类别:
-
资助金额:$41.15万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfe
-
批准号:7337576
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:10012680
-
项目类别:
-
资助金额:$83.87万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Nonmyeloablative allogeneic PBSC in globin disorders
-
批准号:10253825
-
项目类别:
-
资助金额:$144.37万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Development of improved lentiviral vectors for human gene therapy applications
-
批准号:7735061
-
项目类别:
-
资助金额:$16.48万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Nonmyeloablative allogeneic PBSC in globin disorders
-
批准号:10467903
-
项目类别:
-
资助金额:$154.94万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Isolation, characterization, and transplantation of stem
-
批准号:7151527
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
Development of improved lentiviral vectors for human gene therapy applications
-
批准号:7969167
-
项目类别:
-
资助金额:$20.58万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:8557972
-
项目类别:
-
资助金额:$102.13万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
A preclinical large animal model for globin gene transfer
-
批准号:7593476
-
项目类别:
-
资助金额:$48.02万
-
财政年份:--
-
负责人:John Tisdale
-
依托单位:
海外基金